Published in Neuropharmacology on March 23, 2011
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf (2014) 3.23
Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inf Model (2012) 1.29
Impact of tobacco regulation on animal research: new perspectives and opportunities. Nicotine Tob Res (2012) 1.01
Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology (2012) 0.95
Behavioral mechanisms underlying nicotine reinforcement. Curr Top Behav Neurosci (2015) 0.87
Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. J Neurosci (2013) 0.86
A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain. Neuropsychopharmacology (2012) 0.85
Effects of MAO inhibition and a combination of minor alkaloids, β-carbolines, and acetaldehyde on nicotine self-administration in adult male rats. Drug Alcohol Depend (2015) 0.81
Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine. Neuropsychopharmacology (2016) 0.77
Actual causes of death in the United States, 2000. JAMA (2004) 44.38
Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep (2008) 13.54
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (1996) 4.52
Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 2.62
Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) (2005) 2.49
Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry (2007) 2.37
Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology (2005) 1.96
Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav (2000) 1.81
Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) (2004) 1.81
Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 1.78
Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine. J Pharmacol Exp Ther (1972) 1.58
Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci (2005) 1.53
Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology (Berl) (1998) 1.50
The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int J Neuropsychopharmacol (2009) 1.36
Update on pharmacologic options for smoking cessation treatment. Am J Med (2008) 1.34
Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther (1985) 1.32
Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med (2000) 1.25
Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol (2001) 1.16
Monoamine oxidase and tobacco dependence. Neurotoxicology (2006) 1.15
Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology (2007) 1.13
Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans? Pharmacol Biochem Behav (2008) 1.12
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol (2008) 1.08
Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats. J Pharmacol Exp Ther (2007) 1.06
Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos (2001) 1.06
Role of serotonin(2C) receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav (2002) 1.03
Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A. Behav Brain Res (2005) 1.02
The effects of response operandum and prior food training on intravenous nicotine self-administration in rats. Psychopharmacology (Berl) (2010) 1.00
Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology (2005) 1.00
Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci (2006) 0.99
Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther (2001) 0.96
Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves. Chem Res Toxicol (2000) 0.96
Comparison of the apparent antidepressant activity of (-) and (+) tranylcypromine in an animal model. Biochem Pharmacol (1976) 0.96
Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats. Eur J Neurosci (2008) 0.96
Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat. Psychopharmacology (Berl) (2007) 0.94
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol Biochem Behav (2003) 0.90
Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion. Biol Psychiatry (2007) 0.89
The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Behav Pharmacol (2007) 0.87
Nicotinic-serotonergic drug interactions and attentional performance in rats. Psychopharmacology (Berl) (2005) 0.83
Ketanserin attenuates nicotine-induced working memory improvement in rats. Pharmacol Biochem Behav (2005) 0.82
Age, sex and early environment contribute to individual differences in nicotine/acetaldehyde-induced behavioral and endocrine responses in rats. Pharmacol Biochem Behav (2006) 0.82
Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration. Synapse (2010) 0.80
On the role of serotonin2A/2C receptors in the sensitization to cocaine. J Physiol Pharmacol (2001) 0.80
Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice. Eur J Neurosci (2006) 0.80
Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? J Psychiatry Neurosci (2007) 0.80
Lithium and motor activity of animals: effects and possible mechanism of action. Int Pharmacopsychiatry (1980) 0.78
A gas chromatographic procedure for separation and quantitation of the enantiomers of the antidepressant tranylcypromine. Biochem Pharmacol (1992) 0.77
2-SUBSTITUTED CYCLOPROPYLAMINES. I. DERIVATIVES AND ANALOGS OF 2-PHENYLCYCLOPROPYLAMINE. J Med Pharm Chem (1962) 0.77
A comparison of the neurochemical properties of the stereoisomers of tranylcypromine in the central nervous system. Cell Mol Biol (1986) 0.76
Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature (2002) 4.67
The dynamic effects of nicotine on the developing brain. Pharmacol Ther (2009) 3.01
Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science (2005) 2.08
Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology (2005) 1.96
Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) (2004) 1.81
Nicotine and brain development. Birth Defects Res C Embryo Today (2008) 1.80
Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol (2002) 1.68
Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob Res (2007) 1.54
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 1.51
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc Natl Acad Sci U S A (2007) 1.40
Expression of prokineticins and their receptors in the adult mouse brain. J Comp Neurol (2006) 1.34
The melanin-concentrating hormone system modulates cocaine reward. Proc Natl Acad Sci U S A (2009) 1.30
AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology (2012) 1.22
Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicol Teratol (2006) 1.22
Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation. Brain Res Dev Brain Res (2002) 1.21
Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology (2007) 1.13
Tobacco use across the formative years: a road map to developmental vulnerabilities. Nicotine Tob Res (2003) 1.11
Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats. Eur J Neurosci (2006) 1.11
Expression of alpha5 nicotinic acetylcholine receptor subunit mRNA during hippocampal and cortical development. J Comp Neurol (2005) 1.11
Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. Synapse (2007) 1.09
Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats. J Pharmacol Exp Ther (2007) 1.06
Adolescent maturation of cocaine-sensitive neural mechanisms. Neuropsychopharmacology (2007) 1.05
The effects of perinatal choline supplementation on hippocampal cholinergic development in rats exposed to alcohol during the brain growth spurt. Hippocampus (2012) 1.00
Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology (2005) 1.00
Acetaldehyde, a major constituent of tobacco smoke, enhances behavioral, endocrine, and neuronal responses to nicotine in adolescent and adult rats. Neuropsychopharmacology (2007) 0.97
Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats. Eur J Neurosci (2008) 0.96
Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1. Neuroreport (2002) 0.94
Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat. Psychopharmacology (Berl) (2007) 0.94
Nicotine exposure during a postnatal critical period alters NR2A and NR2B mRNA expression in rat auditory forebrain. Brain Res Dev Brain Res (2002) 0.94
Gestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. Int J Neuropsychopharmacol (2010) 0.93
Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism. Neuropsychopharmacology (2011) 0.93
Reversible lipidization for the oral delivery of leu-enkephalin. J Drug Target (2006) 0.93
Age-dependent effects of low-dose nicotine treatment on cocaine-induced behavioral plasticity in rats. Psychopharmacology (Berl) (2009) 0.91
Postnatal development of NR2A and NR2B mRNA expression in rat auditory cortex and thalamus. J Assoc Res Otolaryngol (2002) 0.90
Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats. Int J Neuropsychopharmacol (2010) 0.90
Gestational nicotine-induced changes in adolescent neuronal activity. Brain Res (2006) 0.86
Gestational exposure to nicotine and monoamine oxidase inhibitors influences cocaine-induced locomotion in adolescent rats. Psychopharmacology (Berl) (2007) 0.86
Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia. J Pharmacol Exp Ther (2009) 0.86
Nicotine modulation of stress-related peptide neurons. J Comp Neurol (2006) 0.86
Enaminone amides as novel orally active GABAA receptor modulators. J Med Chem (2007) 0.85
The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders. PLoS One (2011) 0.85
Modifying quinolone antibiotics yields new anxiolytics. Nat Med (2003) 0.84
Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition. J Pharmacol Exp Ther (2010) 0.84
Locomotor and stress responses to nicotine differ in adolescent and adult rats. Pharmacol Biochem Behav (2010) 0.83
Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception. Brain Res (2002) 0.83
Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate. J Nucl Med (2005) 0.83
Age, sex and early environment contribute to individual differences in nicotine/acetaldehyde-induced behavioral and endocrine responses in rats. Pharmacol Biochem Behav (2006) 0.82
Nicotinic acetylcholine receptor subunit mRNA expression in adult and developing rat medullary catecholamine neurons. J Comp Neurol (2008) 0.81
Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development. J Chem Neuroanat (2003) 0.80
3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers. J Med Chem (2004) 0.80
Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration. Synapse (2010) 0.80
Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats. Psychopharmacology (Berl) (2010) 0.79
Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of α7 nicotinic acetylcholine receptors. J Med Chem (2013) 0.78
Synaptoneurosome micromethod for fractionation of mouse and human brain, and primary neuronal cultures. J Neurosci Methods (2012) 0.78
Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroid. Psychopharmacology (Berl) (2014) 0.77
Central myelin gene expression during postnatal development in rats exposed to nicotine gestationally. Neurosci Lett (2013) 0.77
Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulator. J Psychopharmacol (2013) 0.76
Age-dependent alterations in reward-seeking behavior after brief nicotine exposure. Psychopharmacology (Berl) (2013) 0.76
Nicotine-induced brain metabolism associated with anger provocation. Behav Brain Funct (2009) 0.76
Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states. J Pharmacol Exp Ther (2006) 0.76